Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of the National Cancer Institute|April 15, 2016
Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast CancerNathan Simon, Antonella Antignani, Robert Sarnovsky, et al.
JCI Insight|February 6, 2019
Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cellsNathan Simon, Antonella Antignani, Stephen M Hewitt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 2, 2022
Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activityEric Chun Hei Ho, Rong Qiu, Ellis Miller, et al.
Biomolecules|September 22, 2020
Targeting Receptors on Cancer Cells with Protein ToxinsAntonella Antignani, Eric Chun Hei Ho, Maria Teresa Bilotta, et al.
Antibody Therapeutics|February 26, 2019
Generation of antibody-based therapeutics targeting the Idiotype of B-cell MalignanciesEmily Weiss, Robert Sarnovsky, Mitchell Ho, et al.
The Journal of Biological Chemistry|October 7, 2009
Bax activates endophilin B1 oligomerization and lipid membrane vesiculationTatiana K Rostovtseva, Hacène Boukari, Antonella Antignani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicityMatteo Pasetto, Antonella Antignani, Pinar Ormanoglu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 16, 2023
Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cellsAntonella Antignani, Maria Teresa Bilotta, Jacob S Roth, et al.
The Journal of Biological Chemistry|February 14, 2009
Proteolytic cleavage of a C-terminal prosequence, leading to autoprocessing at the N Terminus, activates leucine aminopeptidase from Pseudomonas aeruginosaRobert Sarnovsky, Jennifer Rea, Matt Makowski, et al.
Molecular Cancer Therapeutics|July 1, 2010
ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosolRoberta Traini, Gal Ben-Josef, Diana V Pastrana, et al.
Pageof 3